Insider · CIK 0001869107
James J. Donohue
Files at ACXP (Acurx Pharmaceuticals, Inc.). First filing Jan 8, 2025, latest Jan 8, 2025.
In brief
James J. Donohue files SEC Form 4 as director at ACXP (Acurx Pharmaceuticals, Inc.). Since Jan 8, 2025, James J. Donohue has reported 1 open-market buy worth $10,000 and 0 open-market sells worth $0, the latest filed on Jan 8, 2025.
A track record needs three past buys with six months of prices behind them; James J. Donohue has 0, so none is measured yet.
The newest scored trade: bought $10,000 of ACXP on Jan 6, 2025, filed Jan 8, 2025, scored 40 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ACXP: Acurx Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | Acurx Pharmaceuticals, Inc. | $10,000 9,852 shares | +79% | - |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | ACXP Acurx Pharmaceuticals, Inc. | AGrant or award Stock Optionderivative | +2,150 | $0.00 | $0 | 2,150 | Apr 22, 2026 |
| Jan 6, 2025 | ACXP Acurx Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +9,852 | $1.02 | $10,000 | 22,352 | Jan 8, 2025 |
| Jan 6, 2025 | ACXP Acurx Pharmaceuticals, Inc. | POpen-market purchase Warrants for Common Stockderivative | +9,852 | $0.00 | $0 | 9,852 | Jan 8, 2025 |
Questions about James J. Donohue
Answered from the filings on this page, as of the latest one.
Is James J. Donohue buying or selling?
Not in the last 12 months. James J. Donohue's latest open-market trade on SEC Form 4 was bought $10,000 of ACXP on Jan 6, 2025.
How did James J. Donohue's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and James J. Donohue has 0.
Where does James J. Donohue file Form 4?
James J. Donohue has filed Form 4 at ACXP (Acurx Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.